Susquehanna International Group, LLP Karyopharm Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.06 $43,050 - $65,190	-61,500 Reduced 25.12%	183,300 $152,000
Q2 2024 Aug 15, 2024	BUY	$0.87 - $1.58 $140,505 - $255,170	161,500 Added 193.88%	244,800 $212,000
Q1 2024 May 07, 2024	BUY	$0.72 - $1.66 $19,080 - $43,990	26,500 Added 46.65%	83,300 $125,000
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.31 $272 - $524	400 Added 0.71%	56,800 $48,000
Q3 2023 Nov 14, 2023	BUY	$1.14 - $1.81 $7,865 - $12,489	6,900 Added 13.94%	56,400 $75,000
Q2 2023 Aug 11, 2023	SELL	$1.79 - $4.59 $50,836 - $130,356	-28,400 Reduced 36.46%	49,500 $88,000
Q1 2023 May 16, 2023	SELL	$2.84 - $3.92 $28,400 - $39,200	-10,000 Reduced 11.38%	77,900 $303,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $5.93 $149,048 - $356,393	-60,100 Reduced 40.61%	87,900 $298,000
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $466,752 - $665,808	-114,400 Reduced 43.6%	148,000 $808,000
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $1.38 Million - $2.78 Million	-332,300 Reduced 55.88%	262,400 $1.18 Million
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $3.15 Million - $7.66 Million	532,500 Added 856.11%	594,700 $4.38 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $1,042 - $1,722	200 Added 0.32%	62,200 $400,000
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $373,355 - $891,857	-83,900 Reduced 57.51%	62,000 $361,000
Q2 2021 Aug 11, 2021	BUY	$8.11 - $11.11 $652,044 - $893,244	80,400 Added 122.75%	145,900 $1.51 Million
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $722,990 - $1.3 Million	-73,400 Reduced 52.84%	65,500 $689,000
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $172,630 - $209,718	12,200 Added 9.63%	138,900 $2.15 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $1 Million - $1.4 Million	70,800 Added 126.65%	126,700 $1.85 Million
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $3.21 Million - $4.88 Million	-193,300 Reduced 77.57%	55,900 $1.06 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $1.16 Million - $2.25 Million	-81,000 Reduced 24.53%	249,200 $4.79 Million
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $703,326 - $1.5 Million	76,200 Added 30.0%	330,200 $6.33 Million
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $760,138 - $1.59 Million	134,300 Added 112.2%	254,000 $2.44 Million
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $28,080 - $41,795	-6,500 Reduced 5.15%	119,700 $717,000
Q1 2019 May 15, 2019	BUY	$4.12 - $10.25 $471,328 - $1.17 Million	114,400 Added 969.49%	126,200 $737,000
Q4 2018 Feb 14, 2019	SELL	$8.2 - $16.95 $104,959 - $216,960	-12,800 Reduced 52.03%	11,800 $111,000
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $22,139 - $27,534	-1,300 Reduced 5.02%	24,600 $419,000
Q2 2018 Aug 14, 2018	SELL	$12.0 - $19.88 $1.14 Million - $1.88 Million	-94,800 Reduced 78.54%	25,900 $440,000
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $400,768 - $696,900	40,400 Added 50.31%	120,700 $1.62 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $401,685 - $526,361	43,900 Added 120.6%	80,300 $771,000
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $296,660 - $406,224	36,400	36,400 $400,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$5.51 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.99 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.67 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$3.11 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$3 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $57.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account